Delivery Order SPE2DB24D1201-SPE2DB25FJDRU
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,334.25 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order with an ultimate completion date of July 29, 2025, with performance to take place in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,407.97 for Ozempic 1 mg/dose (4 mg/3 mL) vials on June 4, 2025, with a completion date of June 5, 2025. This firm fixed-price, competitively awarded delivery order represents a small-value pharmaceutical transaction executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,566.65 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. This is a firm fixed price, competitively awarded contract with no set-aside designation, issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,297.71 for Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitive award, issued under a firm fixed-price contract type with no set-aside designation, directs the pharmaceutical distributor to deliver the diabetes medication to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,200.10 for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $31,772.81 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials, with an ultimate completion date of July 17, 2025. This competitive award, issued on July 16, 2025, carries a firm fixed price and involves no set-aside designation. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its primary distribution and pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $3,570.78 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a single transaction under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $41,578.22 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This award represents a competitive...
- The Defense Logistics Agency awarded a delivery order valued at $7,450.02 to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, which was competitively awarded without set-aside provisions, carries a firm fixed price structure with an ultimate completion date of August 18, 2025. Performance will be executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued...
- The Defense Logistics Agency awarded a $11,570.41 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 2 mg/dose (8 mg/3 mL) injectable medication. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by July 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December...
- SPE2DB24D1201Indefinite Delivery Contract
- SPE2DB24D1201-SPE2DB25FJDRUDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,506.64 for Ozempic 2 mg/dose (8 mg/3 ml) 3ml vials, with an ultimate completion date of July 30, 2025. This is a firm fixed-price delivery order issued under a non-competitive set-aside arrangement. The award reflects AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain, delivering this diabetes management medication to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The delivery order represents a small-value transaction within this substantial prime contract vehicle, demonstrating AmerisourceBergen's versatility in fulfilling federal medical supply needs across multiple therapeutic domains for the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 7/29/25 |